Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Peripheral Blood Flow Responses to Electromagnetic Energy

NCT: NCT02370199 · RECRUITING

NCT IDNCT02370199
StatusRECRUITING
Start Date2014-11
Completion2027-12-31

Brief Summary

This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.

Frequently Asked Questions

What is Peripheral Blood Flow Responses to Electromagnetic Energy?

Peripheral Blood Flow Responses to Electromagnetic Energy is a clinical trial registered under NCT02370199. Current status: RECRUITING.

What is the status of NCT02370199?

The current status of NCT02370199 (Peripheral Blood Flow Responses to Electromagnetic Energy) is: RECRUITING.

When did Peripheral Blood Flow Responses to Electromagnetic Energy start?

Peripheral Blood Flow Responses to Electromagnetic Energy started on 2014-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.